Clinical Trials Browser

Completed × OTHER_GOV × nimotuzumab × Clear all

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms